Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PHOTACs enable optical control of protein degradation
Martin Reynders, Bryan S. Matsuura, Marleen Bérouti, et al.
Science Advances (2020) Vol. 6, Iss. 8
Open Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem, Craig M. Crews
Cell (2020) Vol. 181, Iss. 1, pp. 102-114
Open Access | Times Cited: 771
Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials
Roy Weinstain, Tomáš Slanina, Dnyaneshwar Kand, et al.
Chemical Reviews (2020) Vol. 120, Iss. 24, pp. 13135-13272
Open Access | Times Cited: 447
Advancing targeted protein degradation for cancer therapy
Brandon Dale, Meng Cheng, Kwang‐Su Park, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 10, pp. 638-654
Open Access | Times Cited: 428
PROTACs: past, present and future
Ke Li, Craig M. Crews
Chemical Society Reviews (2022) Vol. 51, Iss. 12, pp. 5214-5236
Open Access | Times Cited: 419
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Dhanusha A. Nalawansha, Craig M. Crews
Cell chemical biology (2020) Vol. 27, Iss. 8, pp. 998-1014
Open Access | Times Cited: 334
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Xin Li, Yongcheng Song
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 327
The extracellular matrix in development
David A. Cruz Walma, Kenneth M. Yamada
Development (2020) Vol. 147, Iss. 10
Open Access | Times Cited: 323
Cell cycle on the crossroad of tumorigenesis and cancer therapy
Jing Liu, Yunhua Peng, Wenyi Wei
Trends in Cell Biology (2021) Vol. 32, Iss. 1, pp. 30-44
Open Access | Times Cited: 261
Current strategies for the design of PROTAC linkers: a critical review
Robert I. Troup, Charlene Fallan, Matthias G. J. Baud
Exploration of Targeted Anti-tumor Therapy (2020) Vol. 1, Iss. 5
Open Access | Times Cited: 249
On the Promise of Photopharmacology Using Photoswitches: A Medicinal Chemist’s Perspective
Matthew J. Fuchter
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 20, pp. 11436-11447
Open Access | Times Cited: 233
Reversible Spatiotemporal Control of Induced Protein Degradation by Bistable PhotoPROTACs
Patrick Pfaff, Kusal T. G. Samarasinghe, Craig M. Crews, et al.
ACS Central Science (2019) Vol. 5, Iss. 10, pp. 1682-1690
Open Access | Times Cited: 229
Cancer Selective Target Degradation by Folate-Caged PROTACs
Jing Liu, He Chen, Yi Liu, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 19, pp. 7380-7387
Open Access | Times Cited: 196
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
Sajid Khan, Yonghan He, Xuan Zhang, et al.
Oncogene (2020) Vol. 39, Iss. 26, pp. 4909-4924
Open Access | Times Cited: 189
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Shanique Alabi, Craig M. Crews
Journal of Biological Chemistry (2021) Vol. 296, pp. 100647-100647
Open Access | Times Cited: 188
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Xinyi Li, Wenchen Pu, Qingquan Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 185
Targeted protein degradation: A promise for undruggable proteins
Kusal T. G. Samarasinghe, Craig M. Crews
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 934-951
Open Access | Times Cited: 184
Chemistries of bifunctional PROTAC degraders
Chao-Guo Cao, Ming He, Liguo Wang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 16, pp. 7066-7114
Closed Access | Times Cited: 168
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
Shenxin Zeng, Wenhai Huang, Xiaoliang Zheng, et al.
European Journal of Medicinal Chemistry (2020) Vol. 210, pp. 112981-112981
Closed Access | Times Cited: 164
E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points
Aleša Bricelj, Christian Steinebach, Robert D. Kuchta, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 158
Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic
Zhenyi Hu, Craig M. Crews
ChemBioChem (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 158
Optical Control of Small Molecule-Induced Protein Degradation
Yuta Naro, Kristie Darrah, Alexander Deiters
Journal of the American Chemical Society (2020) Vol. 142, Iss. 5, pp. 2193-2197
Open Access | Times Cited: 155
Targeted protein degradation as a powerful research tool in basic biology and drug target discovery
Tao Wu, Hojong Yoon, Yuan Xiong, et al.
Nature Structural & Molecular Biology (2020) Vol. 27, Iss. 7, pp. 605-614
Open Access | Times Cited: 153
Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective
Laura M. Luh, U. Scheib, Katrin Juenemann, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 36, pp. 15448-15466
Open Access | Times Cited: 149
Target and tissue selectivity of PROTAC degraders
Robert G. Guenette, Seung Wook Yang, Jaeki Min, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 14, pp. 5740-5756
Closed Access | Times Cited: 147
Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation
Yu Chen, Ira Tandon, William J. Heelan, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 13, pp. 5330-5350
Open Access | Times Cited: 137
Page 1 - Next Page

Scroll to top